Aseptic meningitis outbreak associated with echovirus 4 in Northern Europe in 2013-2014.


Journal

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671

Informations de publication

Date de publication:
08 2020
Historique:
received: 30 01 2020
revised: 29 06 2020
accepted: 05 07 2020
pubmed: 12 7 2020
medline: 21 8 2021
entrez: 12 7 2020
Statut: ppublish

Résumé

Picornaviruses (family Picornaviridae) are small, nonenveloped, positive-sense, single-stranded RNA viruses. The members of this family are currently classified into 47 genera and 110 species. Of picornaviruses, entero- and parechoviruses are associated with aseptic meningitis. They are transmitted via fecal-oral and respiratory routes, and occasionally, these viruses may cause a brief viremia and gain access to central nervous system (CNS). During the diagnostic screening of entero- and parechovirus types in Finland in year 2013-14, we detected a cluster of echovirus 4 (E4) infections in young adults and adolescents. As E4 is infrequently detected in Finland, we contacted several Northern and Central European laboratories that conduct routine surveillance for enteroviruses and, for those who have had E4 cases, we send a query for E4 sequences and data. Here we report CNS infections caused by E4 in Finland, Sweden, Norway, Denmark, Iceland and Germany in 2013 and 2014, and show that the E4 detected in these countries form a single lineage. In contrast, E4 strains circulating in these countries preceding the year 2013, and those circulating elsewhere in Europe during 2013-2014, formed several independent clusters.

Identifiants

pubmed: 32652478
pii: S1386-6532(20)30277-8
doi: 10.1016/j.jcv.2020.104535
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104535

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Teemu Smura (T)

University of Helsinki and Helsinki University Hospital, Virology and Immunology, Helsinki, Finland.

Soile Blomqvist (S)

National Institute for Health and Welfare (THL), Department of Health Security, Helsinki, Finland.

Pekka Kolehmainen (P)

University of Helsinki, Department of Virology, Helsinki, Finland.

Isabelle Schuffenecker (I)

Institut des Agents infectieux des HCL, CNR des enterovirus, Hôpital de la Croix-Rousse & Université de Lyon, CIRI INSERM U1111, UCBL, Lyon, France.

Bruno Lina (B)

Institut des Agents infectieux des HCL, CNR des enterovirus, Hôpital de la Croix-Rousse & Université de Lyon, CIRI INSERM U1111, UCBL, Lyon, France.

Sindy Böttcher (S)

Robert Koch Institute, Berlin, Germany.

Sabine Diedrich (S)

Robert Koch Institute, Berlin, Germany.

Arthur Löve (A)

Landspitali, National University Hospital, Reykjavik, Iceland.

Mia Brytting (M)

Folkhälsomyndigheten, Public Health Agency of Sweden, Solna, Sweden.

Elenor Hauzenberger (E)

Folkhälsomyndigheten, Public Health Agency of Sweden, Solna, Sweden.

Susanne Dudman (S)

Norwegian Institute of Public Health, Oslo, Norway.

Olga Ivanova (O)

Chumakov Federal Scientific Center for Research and Development, Moscow, Russia; Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Alexander Lukasev (A)

Chumakov Federal Scientific Center for Research and Development, Moscow, Russia; Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Thea Kølsen Fischer (TK)

Statens Serum Institut, Copenhagen, Denmark.

Sofie Midgley (S)

Statens Serum Institut, Copenhagen, Denmark.

Petri Susi (P)

University of Turku, Institute of Biomedicine, Turku, Finland.

Carita Savolainen-Kopra (C)

National Institute for Health and Welfare (THL), Department of Health Security, Helsinki, Finland.

Maija Lappalainen (M)

University of Helsinki and Helsinki University Hospital, Virology and Immunology, Helsinki, Finland.

Anne J Jääskeläinen (AJ)

University of Helsinki and Helsinki University Hospital, Virology and Immunology, Helsinki, Finland. Electronic address: anne.jaaskelainen@helsinki.fi.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH